1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Zoll Medical Corporation - Product Pipeline Analysis, 2016 Update

Summary

ZOLL Medical Corporation (Zoll), a subsidiary of Asahi Kasei Corporation, is a provider of medical devices and software solutions for advance emergency care. The company designs, manufactures and markets resuscitation devices and systems used for emergency resuscitation of cardiac arrest victims. Its product portfolio includes defibs/monitors, automated CPR, hospital software solutions, ventilators/aspirators, aspirators, wearable defibrillator, power infuser, related accessories and others. Zoll develops technologies and software that help clinicians, emergency medical services (EMS) personnel and lay rescuers advance the practice of resuscitation. Zoll’s products find application in defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. The company operates in North America, Asia-Pacific, Europe, the Middle East and Africa, and Russia, . Zoll is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Zoll Medical Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Zoll Medical Corporation - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Zoll Medical Corporation Company Snapshot 6
Zoll Medical Corporation Company Overview 6
Key Information 7
Zoll Medical Corporation Pipeline Products and Clinical Trials Overview 8
Zoll Medical Corporation - Pipeline Analysis Overview 10
Business Description 10
Zoll Medical Corporation - Major Products and Services 11
Zoll Medical Corporation Pipeline Products by Development Stage 12
Zoll Medical Corporation Clinical Trials by Trial Status 14
Zoll Medical Corporation Pipeline Products Overview 16
AutoPulse Plus 16
AutoPulse Plus Product Overview 16
CirQlator Intrathoracic Pressure Regulator - Pediatric Version 17
CirQlator Intrathoracic Pressure Regulator - Pediatric Version Product Overview 17
ICY Catheter Model IC-3893 18
ICY Catheter Model IC-3893 Product Overview 18
NeuroFlo Catheter - Ischemic Stroke 19
NeuroFlo Catheter - Ischemic Stroke Product Overview 19
Quattro Catheter Model IC-4593 20
Quattro Catheter Model IC-4593 Product Overview 20
Quattro Catheter Model IC-4593 Clinical Trial 21
ResQVENT 22
ResQVENT Product Overview 22
ZOLL IVTM System - Normothermia 23
ZOLL IVTM System - Normothermia Product Overview 23
ZOLL IVTM System - Sudden Cardiac Arrest 24
ZOLL IVTM System - Sudden Cardiac Arrest Product Overview 24
Zoll Medical Corporation - Key Competitors 25
Zoll Medical Corporation - Key Employees 26
Zoll Medical Corporation - Key Employee Biographies 27
Zoll Medical Corporation - Locations And Subsidiaries 28
Head Office 28
Other Locations and Subsidiaries 28
Recent Developments 31
Zoll Medical Corporation, Recent Developments 31
Dec 17, 2015: FDA approves wearable defibrillator for children at risk for sudden cardiac arrest 31
Dec 10, 2015: Saudi Hospital Uses ZOLL AutoPulse to Help Save Lives in the Cath Lab 31
Oct 26, 2015: ZOLL Medical Strongly Supports Changes in AHA 2015 Guidelines 32
Oct 08, 2015: First and Only CPR Device Indicated to Improve Survival from Cardiac Arrest Now Available Nationwide and Already Saving Lives 33
Aug 26, 2015: ZOLL LifeVest Wearable Defibrillator and Temperature Management Solutions to Be Showcased at ESC Congress 2015 33
Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators 34
Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators 35
Jul 16, 2015: ZOLL Announces Release of Its CPR Extract Capability 35
Jul 07, 2015: Institute of Medicine Report Recommends High Priority Actions to Improve Treatment of Cardiac Arrest 36
Jul 07, 2015: Institute of Medicine Report Recommends High Priority Actions to Improve Treatment of Cardiac Arrest 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 39
Disclaimer 39

List of Tables
Zoll Medical Corporation, Key Facts 7
Zoll Medical Corporation Pipeline Products and Clinical Trials Overview 8
Zoll Medical Corporation Pipeline Products by Equipment Type 8
Zoll Medical Corporation Pipeline Products by Indication 9
Zoll Medical Corporation Clinical Trials by Trial Status 9
Zoll Medical Corporation, Major Products and Services 11
Zoll Medical Corporation Number of Pipeline Products by Development Stage 12
Zoll Medical Corporation Pipeline Products Summary by Development Stage 13
Zoll Medical Corporation Clinical Trials by Trial Status 14
Zoll Medical Corporation Clinical Trials Summary 15
AutoPulse Plus - Product Status 16
AutoPulse Plus - Product Description 16
CirQlator Intrathoracic Pressure Regulator - Pediatric Version - Product Status 17
CirQlator Intrathoracic Pressure Regulator - Pediatric Version - Product Description 17
ICY Catheter Model IC-3893 - Product Status 18
ICY Catheter Model IC-3893 - Product Description 18
NeuroFlo Catheter - Ischemic Stroke - Product Status 19
NeuroFlo Catheter - Ischemic Stroke - Product Description 19
Quattro Catheter Model IC-4593 - Product Status 20
Quattro Catheter Model IC-4593 - Product Description 20
Quattro Catheter Model IC-4593 - Reperfusion with Cooling in Cerebral Acute Ischemia II 21
ResQVENT - Product Status 22
ResQVENT - Product Description 22
ZOLL IVTM System - Normothermia - Product Status 23
ZOLL IVTM System - Normothermia - Product Description 23
ZOLL IVTM System - Sudden Cardiac Arrest - Product Status 24
ZOLL IVTM System - Sudden Cardiac Arrest - Product Description 24
Zoll Medical Corporation, Key Employees 26
Zoll Medical Corporation, Key Employee Biographies 27
Zoll Medical Corporation, Other Locations 28
Zoll Medical Corporation, Subsidiaries 29

List of Figures
Zoll Medical Corporation Pipeline Products by Equipment Type 9
Zoll Medical Corporation Pipeline Products by Development Stage 12
Zoll Medical Corporation Clinical Trials by Trial Status 14

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2016

Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glutamyl Aminopeptidase (EAP or Aminopeptidase A or Differentiation Antigen gp160 or CD249 or ENPEP or EC 3.4.11.7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glutamyl Aminopeptidase ...

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) ...

NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NAD(P)H Oxidase or NOX4 or EC 1.6.3.) - Pipeline Review, H2 2016

NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NAD(P)H Oxidase or NOX4 or EC 1.6.3.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NAD(P)H Oxidase or NOX4 or EC 1.6.3.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘NADPH ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.